K.C. Pharmaceuticals recalls millions of eye drops over sterility concerns

K.C. Pharmaceuticals recall overview:

• Who: K.C. Pharmaceuticals is recalling more than three million bottles of eye drops.
• Why: The recall is due to concerns that the products may not be sterile.
• Where: The recall is active nationwide in the United States.

K.C. Pharmaceuticals is recalling more than three million bottles of eye drops due to potential sterility issues, which could lead to temporary adverse health consequences.

The recall, initiated on March 3, involves several batches of eye drops distributed under various brand names, including Walgreens, Kroger and CVS. These products have expiration dates ranging from April to October.

The U.S. Food and Drug Administration (FDA) classified this as a Class II recall on March 31, indicating that while serious health issues are unlikely, there is a risk of temporary adverse effects.

According to the FDA’s enforcement report, the affected products can be identified by their universal product code or national drug code numbers as well as lot code numbers printed on the bottles.

Eye drop recall affects eight types of products across the United States

The eye drops recall affects eight types of eye drop products, each sold under different brand names and distributed to major retailers across the United States. The products include Sterile Eye Drops A.C., Advanced Relief Eye Drops, Dry Eye Relief Eye Drops, Ultra Lubricating Eye Drops and others.

These products are packaged in 0.5 fl oz (15 mL) bottles and can be identified by specific lot codes and expiration dates.

K.C. Pharmaceuticals is actively addressing the issue by notifying retailers and consumers about the K.C. Pharmaceuticals recall through email and other communication channels.

The company is working to ensure that all affected products are removed from shelves and is advising consumers to check their eye drop bottles for the specific lot codes and expiration dates mentioned in the recall.

For more information about the eye drops recall, consumers can contact K.C. Pharmaceuticals via its website or consult the FDA’s  detailed guidance on the affected products and next steps.

K.C. Pharmaceuticals says it has not received any reports of illness or injury related to the recall so far. The company is not currently facing legal action over the K.C. Pharmaceuticals recall, but Top Class Actions follows recalls closely as they sometimes lead to class action lawsuits.

Last year, AvKare recalled more than 75,000 cases of ophthalmic solutions due to potential manufacturing quality deviations.

Are you affected by this K.C. Pharmaceuticals recall? Let us know in the comments.

Read About More Class Action Lawsuits & Class Action Settlements:

• Dorada Foods issues alert for chicken nuggets due to lead contamination
• Judge rules Uber owes ‘non-delegable duty’ to passengers in sexual assault MDL
• John Deere class action settlement includes $99M, right to repair changes
• Abercrombie & Fitch hit with class action over hidden fees added at checkout